Skandinaviska Enskilda Banken (SEB)
ABBV icon

Skandinaviska Enskilda Banken (SEB)’s AbbVie ABBV Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-863,407
Closed -$197M – 164
2025
Q4 		$197M Sell
863,407
-83,968
-9% -$19.1M 0.79% 21
2025
Q3 		$220M Buy
947,375
+62,956
+7% +$12.8M 0.88% 18
2025
Q2 		$164M Sell
884,419
-10,092
-1% -$1.88M 0.72% 21
2025
Q1 		$188M Sell
894,511
-101,646
-10% -$19.8M 0.92% 19
2024
Q4 		$176M Sell
996,157
-352,147
-26% -$64.7M 0.79% 23
2024
Q3 		$266M Sell
1,348,304
-173,641
-11% -$32.4M 1.23% 13
2024
Q2 		$261M Sell
1,521,945
-5,164
-0.3% -$855K 1.25% 14
2024
Q1 		$278M Buy
1,527,109
+270,034
+21% +$46.5M 1.36% 12
2023
Q4 		$195M Buy
1,257,075
+47,201
+4% +$6.88M 1.13% 15
2023
Q3 		$180M Buy
1,209,874
+363,528
+43% +$53.4M 1.18% 14
2023
Q2 		$114M Buy
846,346
+213,494
+34% +$31.3M 0.75% 24
2023
Q1 		$101M Sell
632,852
-174,550
-22% -$26.7M 0.7% 27
2022
Q4 		$130M Sell
807,402
-250,358
-24% -$38.4M 0.98% 15
2022
Q3 		$142M Sell
1,057,760
-122,098
-10% -$17.5M 1.1% 14
2022
Q2 		$181M Sell
1,179,858
-129,310
-10% -$19.8M 1.33% 9
2022
Q1 		$213M Sell
1,309,168
-122,586
-9% -$17.8M 1.25% 12
2021
Q4 		$195M Buy
1,431,754
+512,174
+56% +$60.5M 1% 15
2021
Q3 		$99.3M Buy
919,580
+64,034
+7% +$7.32M 0.54% 37
2021
Q2 		$96.4M Buy
855,546
+37,490
+5% +$4.22M 0.59% 33
2021
Q1 		$88.7M Buy
818,056
+97,620
+14% +$10.4M 0.58% 32
2020
Q4 		$77.2M Buy
720,436
+3,688
+0.5% +$354K 0.53% 36
2020
Q3 		$62.8M Buy
716,748
+56,760
+9% +$5.34M 0.46% 49
2020
Q2 		$64.8M Buy
659,988
+73,217
+12% +$6.45M 0.52% 40
2020
Q1 		$44.7M Sell
586,771
-22,414
-4% -$1.91M 0.45% 47
2019
Q4 		$53.9M Sell
609,185
-799,090
-57% -$66.3M 0.42% 56
2019
Q3 		$107M Buy
1,408,275
+60,422
+4% +$4.14M 0.9% 26
2019
Q2 		$98M Buy
1,347,853
+333,183
+33% +$26.2M 0.85% 25
2019
Q1 		$81.8M Sell
1,014,670
-50,199
-5% -$4.11M 0.75% 31
2018
Q4 		$98.2M Buy
1,064,869
+69,605
+7% +$6.12M 0.88% 28
2018
Q3 		$94.1M Sell
995,264
-11,990
-1% -$1.14M 0.72% 33
2018
Q2 		$93.3M Buy
1,007,254
+87,189
+9% +$8.52M 0.8% 30
2018
Q1 		$87.1M Sell
920,065
-109,787
-11% -$12.1M 0.84% 30
2017
Q4 		$99.6M Sell
1,029,852
-99,610
-9% -$9.39M 0.86% 30
2017
Q3 		$100M Sell
1,129,462
-89,700
-7% -$6.83M 0.91% 23
2017
Q2 		$88.4M Buy
1,219,162
+16,679
+1% +$1.12M 0.85% 25
2017
Q1 		$78.4M Buy
1,202,483
+357,353
+42% +$22.5M 0.79% 31
2016
Q4 		$52.9M Buy
845,130
+363,291
+75% +$22.2M 0.64% 35
2016
Q3 		$30.4M Buy
481,839
+179,721
+59% +$11.6M 0.33% 67
2016
Q2 		$18.7M Sell
302,118
-800,600
-73% -$48.8M 0.21% 89
2016
Q1 		$63M Sell
1,102,718
-174,500
-14% -$9.73M 0.71% 29
2015
Q4 		$75.7M Buy
+1,277,218
New +$73.6M 0.98% 22

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ABBV Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 863,407 shares — an estimated $197M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ABBV in Q4 2015 and held it in 41 quarters. The position peaked at $278M in Q1 2024. 4,082 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 863,407 AbbVie shares in Q1 2026, an estimated $197M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in AbbVie in Q4 2015 and held it in 41 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s AbbVie position peaked at $278M in Q1 2024.
  • 4,082 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.